LeafNLP Demos
Back to explore

Report #2889085

Received Mar 16, 2026

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Male
Age
66 yrs
State
IA
Recovered
Unknown
Vaccinated
Feb 11, 2026
Onset
Feb 11, 2026
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALSUNK79MR9—

Symptoms (1)

Product preparation issue

Symptom narrative

patient have received only the diluent portion of Shingrix; patient have received only the diluent portion of Shingrix; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 66-year-old male patient who received Herpes zoster (Shingrix) (batch number 79MR9, expiry date 26-AUG-2027) for prophylaxis. On 11-FEB-2026, the patient received Shingrix. On 11-FEB-2026, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: patient have received only the diluent portion of Shingrix) and inappropriate dose of vaccine administered (Verbatim: patient have received only the diluent portion of Shingrix). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK receipt date: 10-MAR-2026 The patient had received only the diluent portion of Shingrix and wanted to know how to proceed. This was 1 of 3 linked cases, reported by the same reporter.; Sender's Comments: US-GSK-US2026033729:Same reporter/Different patient US-GSK-US2026033733:Same reporter/Different patient